Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000947871-26-000996·Aspen Neuroscience, Inc.
Schedule 13D ownership disclosure
Aspen Neuroscience, Inc.
COMMON STOCK · CUSIP: 044933109
Event date: 2026-11-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLCReported CIK 0001055951
Shares: 3,589,132.00 · Class: 12.3%
- ORBIMED CAPITAL GP VII LLCReported CIK 0001760648
Shares: 3,589,132.00 · Class: 12.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-26-000996
- Form type
- SCHEDULE 13D
- Filer
- Aspen Neuroscience, Inc.
- CIK
- CIK 2124080
- Filed
- Nov 06, 2026
- Reporting period
- Nov 02, 2026
- Description
- Schedule 13D beneficial ownership